Among the symptoms of flawed hip devices are pain on the hip area, pain on the thigh or groin area, pain while walking, pain when rising from a seated position, pain bearing weight and swelling.
Legal observers say that the DePuy hip replacement lawsuit should be a learning example to other manufacturing companies to ensure safety of their products. For more inputs just visit here at this webiste: www.depuysettlements.com
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Graphite may prevent complications caused by the device
1.
2. The use of graphite compound maybe helpful in
designing safer hip replacement devices, research
says. The beneficial effect of graphite was based on a
recent research funded by the National Institutes of
Health that was published in the medical journal,
Science. The European Parliament has taken steps
towards establishing a European Union medical
device registry.
“Graphite has been used as a lubricant for over a
century. It is a classic lubricant, and it appears to
form naturally,” explains Laurence Marks. He is
one of the study researchers and a professor of
materials science and engineering at Northwestern
University. The research team were composed of
medical experts and engineers from Northwestern,
Rush University Medical Center in Chicago and
University of Duisburg-Essen in Germany.
3. Hip implant product manufacturers include DePuy Orthopaedics Inc.,
Wright Medical Group Inc, Smith & Nephew PLC and Zimmer Holdings Inc.
Depuy, which is a subsidiary company of Johnson & Johnson, enforced a
global pullback of their devices in August 2010. In 2003, two of its designs
of artificial hip first rolled out of the factory in 2003 and sold to the public.
Johnson & Johnson have been charged with compensatory claims by their
patrons, legal specialists say. They were the victims of DePuy hip implants
failures and defects such as loosening, fractures, and displacements. In May
2011, medical practitioners and engineers formed a registry for tracking of
hip and knee implants, following the DePuy hip replacement recall. It was
called American Joint Replacement Registry (AJRR).
4. “The goal is to track the more than 700,000 total hip and knee
replacement surgeries that take place in the U.S. each year and, over
time, record which implants failed prematurely, requiring revision
surgery to fix the original operation,” according to David Lewallen,
professor of orthopedic surgery at the Mayo Clinic in Rochester,
Minnesota and AJRR chairman.
Among the health risks allegedly caused by DePuy hip devices are cancer
due to the presence of chromium and cobalt in the blood, unexplained
hip pain, hip dislocation, metal toxicity (metallosis), loosening of hip
device, additional hip replacement surgery, detachment of hip device
from the bone, pseudotumors, genetic damage (genotoxicty), bone
fractures, bone loss, and tissue damages.
5. Among the symptoms of flawed hip
devices are pain on the hip area, pain on
the thigh or groin area, pain while
walking, pain when rising from a seated
position, pain bearing weight and
swelling.
Legal observers say that the DePuy hip
replacement lawsuit should be a learning
example to other manufacturing
companies to ensure safety of their
products.
6. According to www.depuysettlements.com, the DePuy hip
replacement lawsuits should stand as a lesson to other device
manufacturers to strengthen and certify the safety of their
products.
References:
businessweek.com/news/2011-05-03/medical-groups-
tracking-hip-knee-implants-after-j-j-recall.html
usrecallnews.com/2010/09/depuy-hip-replacement-recalled-
asr-artificial-hip-systems.html
nytimes.com/2010/08/27/business/27hip.html